Prescribing Information Forxiga® (dapagliflozin) Great Britain

Adverse Event Reporting

Astrazeneca

Contact Us

Janrain Redirect Login
AZ Employee Login
  • EN
  • FR
Logo test product
  • Our medicines Test Title
    • Cardio Vascular Test test test test test test test test
      • Heart Failure
        • Brilique® (Ticagrelor)
          • test
        • Forxiga-dapagliflozin
          • Forxiga® (dapagliflozin)
      • CKD
      • Type 2 Diabetes
      • Test list 3rd level
        • test link 4th level
    • Respiratory and oncology Test test test test test test test test test test test test
      • Breast Cancer
        • Generic List - 1
          • item 0
          • item 1
      • Hematology
      • Liver Cancer
      • Biliary Tract Cancer
      • Lung Cancer
        • Resectable Stage IB - IIIA EGFRm NSCLC
          • Tagrisso® (Osimertinib)
          • Imfinzi® (Durvalumab)
          • Enhertu® (Trastuzumab Deruxtecan)
          • Datroway® (Datopotamab Deruxtecan)
          • Orpathys® (Savolitinib)
          • Monalizumab
          • Oleclumab
          • Domvanalimab
          • Volrustomig
          • Rilvegostomig
        • Advanced-metastatic-Stage-IV-EGFRm-NSCLC
          • Advanced metastatic (Stage IV) EGFRm NSCLC
        • Advanced-metastatic
          • Advanced metastatic (Stage IV) EGFRm NSCLC, TAGRISSO with platinum pemetrexed chemotherapy
        • Unresectable Stage III EGFRm NSCLC
          • test 5th level FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
        • test-pr
          • test-pr
      • Mesothelioma
      • Ovarian Cancer
      • Endometrial Cancer
      • Cervical Cancer
      • Prostate Cancer
      • Bladder Cancer
      • Gastric Cancer
      • Head and Neck
      • Pancreatic Cancer
    • Heart failure testing
      • Brilique® (Ticagrelor)
        • test
    • List 2nd level test
    • View all medicines
Login

  • Home
  • Products

3.0 Products Overview1

Lorem ipsum dolor sit amet, consectetur2 adipiscing elit, sed do eiusmod tempor3 incididunt ut labore et dolore magna aliqua.

Button
  1. CVRM
  2. R&I
  3. ONCO

Introduction block a

Lorem6 ipsum dolor sit amet, consectetur7 adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lynparza4

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt5

gg/mm/yyyy

Product 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt

gg/mm/yyyy

Load more Alt text icon

Parent page

Lorem ipsum dolor sit amet


Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Connessiallasalute.it

The AstraZeneca portal was created with the intention of proposing a space for digital dialogue between doctors, specialists and the company.

Privacy Notice

Cookie Notice

Prescribing Information

Important Safety Information

Legal Statement

Site Map

AstraZeneca

Contact Us

LinkedIn

Facebook

YouTube

Instagram

Twitter

A project by:

logo astrazeneca

Blueprint HCP Portal

La información contenida en este sitio web está dirigida exclusivamente a profesional sanitario facultado para prescribir o dispensar medicamentos en España (requiere una formación especializada para su correcta interpretación)

AstraZeneca promueve la prescripción de sus productos farmacéuticos en las condiciones establecidas en su ficha técnica.

NO